CorrlensCorrlens
Correlate

Correlation Analysis

Amgen Inc vs BERKSHIRE HATHAWAY Class B

AMGN vs BRK.B

+0.791

Strong positive

When one moves up, the other tends to follow.

AMGN logo

Amgen Inc

AMGN

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Market cap 184.7B

BRK.B logo

BERKSHIRE HATHAWAY Class B

BRK.B

Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from its operations to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the companies that make up its manufacturing, service, and retailing operations (which include Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis. Berkshire is expected to generate close to $375 billion in revenue in 2025.

Market cap 1T

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: AMGNGray: BRK.B36 of 1,254 points (sampled)

Who Moves First

in sync

AMGN and BRK.B tend to move at the same time.

After testing 13 timing shifts, the strongest relationship was +0.791 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.002

12 periods · Return correlation when both series rose

Both Falling

-0.468

5 periods · Return correlation when both series fell

Diverging

-0.674

18 periods · Return correlation when series moved apart

R-Squared

62.5%

Share of variance in one series explained by the other.

Trend Agreement

62.0%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.769, 0.811]

Scatter

XY Regression

197.3200250300350378.7247250300350400450500522.1Amgen IncBERKSHIRE HATHAWAY Class BData pointsFit (r = 0.791)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

AMGN logo

Amgen Inc

AMGN

Market cap 184.7B

Stock · 1,254 raw → 1,254 prepared

Series B

BRK.B logo

BERKSHIRE HATHAWAY Class B

BRK.B

Market cap 1T

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

31

Estimated crossover points between normalized spreads.

Slope

1.6838

Linear regression slope.

Intercept

-77.6428

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 6 hours ago · ID: stock-amgn-vs-stock-brk-b-daily